![]() Monopar Therapeutics Monopar Therapeutics is a biopharmaceutical company focused on developing innovative drugs and drug combinations to improve clinical outcomes for cancer patients. | ![]() Innate Pharma Innate Pharma is a clinical-stage biotechnology company with a focus on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients. | ![]() OncoDNA OncoDNA is a cancer theranostic company which uses a combination of the relevant molecular technologies to support oncologists in their treatment decisions for patients. | |
Founding Date | Founding Date 2014 | Founding Date 1999 | Founding Date 2012 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Wilmette, US HQ | Locations Marseille, FR HQ Rockville, US | Locations Charleroi, BE HQ |
Employees | Employees 4 | Employees 181 | Employees 502% increase |
Valuation ($) | Valuation ($) 57.1 m | Valuation ($) 148.6 m | Valuation ($) N/A |
Financial | |||
Net income | Net income ($13.6m) (FY, 2025) | Net income (€49.2m) (FY, 2025) | Net income N/A |
Operating ⚠ | |||
Phase I Trials Products | Phase I Trials Products 1 (Sep, 2019) | Phase I Trials Products 3 (Q2, 2019) | Phase I Trials Products N/A |
Phase II Trials Products | Phase II Trials Products 1 (Sep, 2019) | Phase II Trials Products 5 (Q2, 2019) | Phase II Trials Products N/A |
Pre-Clinical Phase Products | Pre-Clinical Phase Products 1 (FY, 2018) | Pre-Clinical Phase Products 7 (Q2, 2019) | Pre-Clinical Phase Products N/A |
Funding | |||
Total funding raised | Total funding raised $ 2.1m | Total funding raised $ 94.1m | Total funding raised $ 29.8m |

Innate Pharma is a clinical-stage biotechnology company with a focus on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients.
View company
OncoDNA is a cancer theranostic company which uses a combination of the relevant molecular technologies to support oncologists in their treatment decisions for patients.
View company